213 related articles for article (PubMed ID: 27029431)
1. A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder.
Ma E; Vetter J; Bliss L; Lai HH; Mysorekar IU; Jain S
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F28-34. PubMed ID: 27029431
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
3. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
4. Elevated CXC chemokines in urine noninvasively discriminate OAB from UTI.
Tyagi P; Tyagi V; Qu X; Chuang YC; Kuo HC; Chancellor M
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F548-54. PubMed ID: 27335375
[TBL] [Abstract][Full Text] [Related]
5. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
[TBL] [Abstract][Full Text] [Related]
6. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder.
Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM
Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264
[TBL] [Abstract][Full Text] [Related]
7. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder.
Clemens JQ; Bogart LM; Liu K; Pham C; Suttorp M; Berry SH
Neurourol Urodyn; 2011 Mar; 30(3):402-5. PubMed ID: 21412821
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
Ke H; Zhu L; Wang Q; Xu K
BMC Urol; 2023 Nov; 23(1):180. PubMed ID: 37940904
[TBL] [Abstract][Full Text] [Related]
10. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction.
Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL
medRxiv; 2023 Apr; ():. PubMed ID: 37131628
[TBL] [Abstract][Full Text] [Related]
11. The Severity and Distribution of Nonurologic Pain and Urogenital Pain in Overactive Bladder are Intermediate Between Interstitial Cystitis and Controls.
Thu JHL; Vetter J; Lai HH
Urology; 2019 Aug; 130():59-64. PubMed ID: 31034917
[TBL] [Abstract][Full Text] [Related]
12. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score.
Humphrey L; Arbuckle R; Moldwin R; Nordling J; van de Merwe JP; Meunier J; Crook T; Abraham L
Eur Urol; 2012 Feb; 61(2):271-9. PubMed ID: 22050826
[TBL] [Abstract][Full Text] [Related]
13. Adverse Childhood Experiences in Women With Overactive Bladder or Interstitial Cystitis/Bladder Pain Syndrome.
Komesu YM; Petersen TR; Krantz TE; Ninivaggio CS; Jeppson PC; Meriwether KV; Dunivan GC
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e208-e214. PubMed ID: 33369968
[TBL] [Abstract][Full Text] [Related]
14. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
Kuo YC; Kuo HC
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
[TBL] [Abstract][Full Text] [Related]
15. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
16. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.
Furuta A; Yamamoto T; Suzuki Y; Gotoh M; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Jul; 29(7):961-966. PubMed ID: 29372285
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Urinary Cytokine Expression and Quality of Life in Patients With Overactive Bladder.
Pillalamarri N; Shalom DF; Pilkinton ML; Winkler HA; Chatterjee PK; Solanki M; Metz CN
Female Pelvic Med Reconstr Surg; 2018; 24(6):449-453. PubMed ID: 28953078
[TBL] [Abstract][Full Text] [Related]
18. Exploring biomarkers in the overactive bladder: Alterations in miRNA levels of a panel of genes in patients with OAB.
Fırat E; Aybek Z; Akgün Ş; Küçüker K; Akça H; Aybek H
Neurourol Urodyn; 2019 Aug; 38(6):1571-1578. PubMed ID: 31157926
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome.
Dobberfuhl AD
Neurourol Urodyn; 2022 Nov; 41(8):1958-1966. PubMed ID: 35607890
[TBL] [Abstract][Full Text] [Related]
20. Assessment of bladder pressure and discomfort symptoms: How do overactive bladder differ from interstitial cystitis/bladder pain syndrome patients?
Gousse A; Vetter J; Lai HH
BMC Urol; 2023 Mar; 23(1):53. PubMed ID: 36997906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
